Nitric oxide (NO) is a biologically active substance that affects not only the vasodilation processes, but also participates in the modulation of a number of processes in the body, including the liver. However, its role in bile secretion remains unclarified. In the research we studied the effect of NO synthesis modulators on parameters of biliary function and bile synthesis of liver in healthy rats. We determined the intensity of bile secretion, content and the concentration of its major components, namely bilirubin and its fractions, cholesterol and bile acids, the ratio bile acids/cholesterol. The precursors of NO synthesis, namely L-arginine and L-glutamate L-arginine (“Glutargine” drug of pharmaceutical company “Zdorovia”) were found to cause choleretic effect. A tendency to increase in both bilirubin and bile acids was observed, mainly due to the conjugated forms of the enzyme. The ratio between the bile components was unchanged, indicating to preservation of bile lithogenic properties.
Moncada S., Higgs A. The L-arginine-nitric oxide pathway . N. Engl. J. Med. 1993; 29: 2002–2012.
Trauner M., Nathanson M.H., Rydberg St.A. [et al.]Endotoxin impairs biliary glutathione and HCO3–excretion and blocks the choleretic effect of nitric oxide in rat liver. Hepatology.1997; 25: 1184–1191.
Spitzer J.A. Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats. Hepatology. 1994; 19: 217–218.
Thippeswamy T., McKay J. S., Quinn J. P. [et al.] Nitric oxide, a biological double–faced Janus––is this good or bad? Histol Histopathol. 2006; 21(4): 445–458.
Oleshchuk O.M. Experimental study of nitric oxide precursors in hepatic ischemia-reperfusion. Shpytalna khirurgiia. 2012; 4: 42–47.
Dufour JF, Turner T., Arias I.M. Nitric oxide blocks bile canalicular contraction by inhibiting inositol trisphosphate-dependent calcium mobilization. Gastroenterology. 1995; 108: 841-849.
Burgstahler A. D., Nathanson M. H. NO modulates the apicolateral cytoskeleton of isolated rat hepatocytes by a PKC-dependent, cGMP-independent mechanism. Am. J. Physiol. 1995; 269: 789–799.
Myers N. C. , Gruene S. , Jameson H. L. , Anwer M. S Cyclic GMP stimulates bile acid independent bile formation and biliary bicarbonate excretion. Am J Physiol. 1996; 270: 418–424.
Matiash V. I., Pechinka A. M., Minova L. V. Therapeutic aspects of glutargin (brief review of published data). Suchasni infektsii. 2007; 3: 56-59.
Skakun N.P., Buniak O.V. Daily changes in liver response to the introduction of dehydrocholic acid. Farmakologiia i toksikologiia. 1980; 15: 70–72.
Drogovoz S.М., Salnikova С.I., Skakun N.P, Slyshkov V.V.Guidelines for the experimental study of choleretic, cholespasmatic, cholelitiatic and hepatoprotective activity of new drugs. Kyiv, 1994: 46.
Miroshnichenko V. P., Gaidai V. N. Photometric determination of the total content, the content of three- and dyoxicholanic bile acids in bile by the reaction of Pettenkofer. Lab. delo.1980; 7: 448.
Miroshnichenko V. P., Gromashevskaya L.L., Kasatkina M.G. [at al.] Determination of bile acids and cholesterol in bile. Lab. delo.1978; 3: 149–153.
Skakun N. P. Experimental insular diabetes and liver function.Thesis. Moskow. 1956: 238–241.
Nikitenko Т. М. Indicators for bile lithogenicity, blood serum lipids and inflammation of the gall bladder in women with cholesterol gallstone disease. Bulletin SB RAMS. 2006; 4 (122): 160–163.
Trauner M., Nathanson M.H., Mennone A. [et al.] Nitric Oxide Donors Stimulate Bile Flow and Glutathione Disulfide Excretion Independent of Guanosine 3,5-Cyclic Monophosphate in the Isolated Perfused Rat Liver. Hepatology. 1997; 25 (2): 263–269.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.